Blinatumomab for Minimal Residual Disease Clearance in B-Acute Lymphoblastic Leukemia. AMMS [Internet]. 2026 Mar. 1 [cited 2026 Mar. 7];:267-72. Available from: https://ammspub.com/index.php/amms/article/view/488